REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Xiamen Amoytop Biotech Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Xiamen Amoytop Biotech Co., Ltd. Profile Updated: May 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Xiamen Amoytop Biotech Co., Ltd. is a biopharmaceutical company that specializes in the research, production and sale of recombinant proteins and long-lasting modified drugs. The company’s launched products include polyglycol interferon α-2b injection, recombinant human granulocytomestome injection, injection recombinant human granulocytosis macrophage stimulator and injection recombinant human leukone-11. The company was founded in 1996, and headquartered in Xiamen City, China.

Headquarters
No. 330, Weng Jiao Road, Haicang Xinyang Industrial Zone, Xiamen City, Fujian Province
Xiamen; Fujian; Postal Code: 361028

Contact Details: Purchase the Xiamen Amoytop Biotech Co., Ltd. report to view the information.

Website: http://www.amoytop.com

Basic Information
Total Employees:
Purchase the Xiamen Amoytop Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Xiamen Amoytop Biotech Co., Ltd. report to view the information.
Registered Capital:
Purchase the Xiamen Amoytop Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Xiamen Amoytop Biotech Co., Ltd. report to view the information.
Incorporation Date:
August 07, 1996
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
33.94%
Purchase this report to view the information.
16.03%
Purchase this report to view the information.
8%
Purchase this report to view the information.
4.97%
Purchase this report to view the information.
2.81%
Subsidiaries
Hainan Youmai Medical Technology Co., Ltd.
100%
Xiamen Bosai Gene Transcription Technology Co., Ltd.
100%
Xiamen Haicang Anmu Duokang Internal Medicine Clinic Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Xiamen Amoytop Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
30.05%▲
Total operating revenue
29.79%▲
Operating profit (EBIT)
43.3%▲
EBITDA
43.85%▲
Net Profit (Loss) for the Period
53.03%▲
Total assets
31.54%▲
Total equity
34.42%▲
Operating Profit Margin (ROS)
2.89%▲
Net Profit Margin
3.55%▲
Return on Equity (ROE)
0.78%▲
Quick Ratio
0.02%▲
Cash Ratio
-0.14%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Hubei Biocause Pharmaceutical Co.,Ltd.
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Beijing Strong Biotechnologies,Inc.
 
Jinyu Bio-Technology Co.,Ltd.
Hainan Huluwa Pharmaceutical Group Co., Ltd.
 
Chengdu Kanghua Biological Products Co., Ltd.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo